LSPedia Introduces New Traceability Solution
OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.
LSPedia, a provider of software-as-a-service (SaaS) traceability solutions for the pharmaceutical industry, has officially launched OneScan 7.1, a traceability platform utilized by brands, such as Cencora, Cardinal Health, and Walmart Health, among others. The goal of OneScan 7.1 is to boost compliance, traceability, and supply chain efficiency.
The solution offers traceability features that allows pharma companies to track and manage products on a global scale by enhancing transparency efforts, while simplifying operations.
When it comes to compliance, LSPedia’s Compliance Cloud has been improved upon. There are now even more developed functionalities that are expected to improve adherence efforts when it comes to meeting not only United States but global regulatory standards, such as the Drug Supply Chain Security Act (DSCSA), current good manufacturing practices (cGMPs), CFR21 Part 11, the Food Safety Modernization Act (FSMA), EU Falsified Medicines Directive (FMD), and more.
Another OneScan 7.1 feature is the “Supplier Management Power Bundle,” which is dedicated to tackling operational exceptions. With the ability to handle risks surrounding compliance, operational inefficiencies, and data frictions, the solution provides exception handling in real-time, along with efficient supplier relationship management.
"OneScan 7.1 is a game-changer for LSPedia and the pharmaceutical industry. We have not only met current challenges but have anticipated future needs,” said Riya Cao, CEO of LSPedia. “The introduction of global traceability, enhanced compliance features, and our commitment to data-driven insights make OneScan 7.1 an indispensable solution for pharmaceutical companies seeking innovation and excellence."
Reference
LSPedia Unveils OneScan 7.1: A Leap into the Future of Pharma Traceability and Compliance. LSPedia. News release. February 13, 2024. Accessed February 22, 2024. https://www.lspedia.com/blog/lspedia-unveils-onescan-7-1-a-leap-into-the-future-of-pharma-traceability-and-compliance
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
